Control of tumor development by intratumoral cytokines

被引：26

作者：

Pages, F

Vives, V

Sautès-Fridman, C

Fossiez, F

Berger, A

Cugnenc, PH

Tartour, E

Fridman, WH

机构：

[1] Inst Curie, INSERM U255, F-75005 Paris, France

[2] Shering Plough, Dardilly, France

[3] Serv Chirurg Gen & Digest, Paris, France

来源：

IMMUNOLOGY LETTERS | 1999年 / 68卷 / 01期

关键词：

cancer; interleukin-17; interferon-gamma; interleukin-18;

D O I：

10.1016/S0165-2478(99)00042-5

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The local immune reactions may influence the clinical outcome of human tumors. In carcinoma of the cervix, high gene expression of IL6 with tumor invasiveness whereas lack of gene expression of IFN beta is correlated with poor prognosis. In colorectal cancer, lack of expression of IFN beta is associated with the presence of distant metastasis and poor survival. The production of IL17 and IL18, inducers of IL6 and IFN beta respectively is regulated in these tumors and may control the levels of the effector cytokines, i.e. IL6 and IFN beta. The mechanisms by which these cytokines act are linked to the recruitment of effector cells such as macrophages. (C) 1999 Elsevier Science B.V. All rights reserved.

引用

收藏

页码：135 / 139

页数：5

相关论文

共 25 条

[1] TGF-BETA EXPRESSION IN THE HUMAN COLON - DIFFERENTIAL IMMUNOSTAINING ALONG CRYPT EPITHELIUM [J].

AVERY, A ;

PARASKEVA, C ;

HALL, P ;

FLANDERS, KC ;

SPORN, M ;

MOORGHEN, M .

BRITISH JOURNAL OF CANCER, 1993, 68 (01) :137-139

[2] Tumor antigens recognized by T cells [J].

Boon, T ;

Coulie, PG ;

VandenEynde, B .

IMMUNOLOGY TODAY, 1997, 18 (06) :267-268

[3]

CAR Z, 1996, INT J CANCER, V68, P535

[4] Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: Time to consider the TH1/TH2 paradigm [J].

Clerici, M ;

Shearer, GM ;

Clerici, E .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (04) :261-263

[5] T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines [J].

Fossiez, F ;

Djossou, O ;

Chomarat, P ;

FloresRomo, L ;

AitYahia, S ;

Maat, C ;

Pin, JJ ;

Garrone, P ;

Garcia, E ;

Saeland, S ;

Blanchard, D ;

Gaillard, C ;

DasMahapatra, B ;

Rouvier, E ;

Golstein, P ;

Banchereau, J ;

Lebecque, S .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2593-2603

[6] Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production [J].

Ghayur, T ;

Banerjee, S ;

Hugunin, M ;

Butler, D ;

Herzog, L ;

Carter, A ;

Quintal, L ;

Sekut, L ;

Talanian, R ;

Paskind, M ;

Wong, W ;

Kamen, R ;

Tracey, D ;

Allen, H .

NATURE, 1997, 386 (6625) :619-623

[7] Activation of interferon-gamma inducing factor mediated by interleukin-1 beta converting enzyme [J].

Gu, Y ;

Kuida, K ;

Tsutsui, H ;

Ku, G ;

Hsiao, K ;

Fleming, MA ;

Hayashi, N ;

Higashino, K ;

Okamura, H ;

Nakanishi, K ;

Kurimoto, M ;

Tanimoto, T ;

Flavell, RA ;

Sato, V ;

Harding, MW ;

Livingston, DJ ;

Su, MSS .

SCIENCE, 1997, 275 (5297) :206-209

[8] NATURAL CYTOTOXIC REACTIVITY OF MOUSE LYMPHOID-CELLS AGAINST SYNGENEIC AND ALLOGENEIC TUMORS .2. CHARACTERIZATION OF EFFECTOR CELLS [J].

HERBERMAN, RB ;

NUNN, ME ;

HOLDEN, HT ;

LAVRIN, DH .

INTERNATIONAL JOURNAL OF CANCER, 1975, 16 (02) :230-239

[9] ALTERED HLA EXPRESSION BY METASTATIC CERVICAL-CARCINOMA CELLS AS A FACTOR IN IMPAIRED IMMUNE SURVEILLANCE [J].

HILDERS, CGJM ;

MUNOZ, IM ;

NOOYEN, Y ;

FLEUREN, GJ .

GYNECOLOGIC ONCOLOGY, 1995, 57 (03) :366-375

[10]

Jovanovic DV, 1998, J IMMUNOL, V160, P3513